ReThink Pharmaceuticals ^{For Profit}

ReThink offers a distinct algorithm based on evolutionary genomics (Phylogenetic Profiling) and innovative bioinformatics for drug repurposing. They discover new indications for drugs in the market and under clinical development, as well as shelved drugs which failed for efficacy reasons in clinical trials. Their breakthrough approach goes beyond the boundaries of published data (whereas other companies are based on the same data-sets) dramatically expanding the spectrum of connections between drugs and diseases that allows them to generate novel and highly accurate findings. They look to work in partnership and collaboration with the pharma industry, medical institutions and rare disease foundations to create value by enhancing the potential clinical and commercial success of repurposing options for existing assets.